# Grey Wolf Therapeutics

**Canonical:** https://apis.io/providers/grey-wolf-therapeutics/  
**Website:** https://greywolftherapeutics.com/  
**APIs profiled:** 0

Grey Wolf Therapeutics (Greywolf Therapeutics) is a clinical-stage biotechnology company developing a new therapeutic class of immunotherapies through antigen modulation, aimed at treating people living with cancers and autoimmune disorders. Its approach modulates antigen presentation on cell surfaces so T cells can correctly recognize and target diseased cells, and it is pioneering modulation of Signal 1 in the T cell activation cascade. Lead assets include GRWD5769, a first-in-class oral ERAP1 inhibitor for oncology in Phase 1/2 trials, and GRWD0715, an autoimmunity-focused asset also in Phase 1/2. Backed by Canaan Partners, the company was added to the API Evangelist network as a venture-portfolio company profile. It is a corporate/scientific organization and publishes no public developer API, OpenAPI, SDK, or developer portal.

## Kin Score — 7.6 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 7.6).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 7.1 |
| Commercial Clarity | 10.5 |
| Access Clarity | 10.5 |

Regulatory layer — **Health**: 12.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Grey Wolf Therapeutics Domain Security** — TLSv1.3 · HSTS · DMARC

## Tags

Company, Biotechnology, Pharmaceuticals, Immuno-Oncology, Immunotherapy, Antigen Modulation, ERAP1, Autoimmune, Oncology, Clinical Stage

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/grey-wolf-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.